Navigation Links
Cueva Cranial Nerve Electrodes

ProductsCueva Cranial Nerve Electrodes
Company Ad-Tech Medical
Item Cueva Cranial Nerve Electrodes
Features 
  • Supplied in complete sterile kits
  • Platinum contacts
  • Easy-to-use applicator
  • Circumferential design; attaches directly to the nerve, yet does not cause trauma
  • Highly-consistent amplitude; real-time status q 25 cm long applicator wand
  • 2.0 mm or 3.0 mm diameter "C-shaped electrode
  • 2.35 mm diameter platinum contact strip electrode (for the middle fossa approach)
  • Sterile; single-use only
    • Description Ad-Techs Cueva Cranial Nerve Electrodes provide direct cranial nerve monitoring during skull base surgeries. Their patented circumferential design provides sensitive contact on the nerve, and yields high-quality, stable real-time recordings. This unique approach provides you with valuable information during the removal of acoustic neuromas, microvascular decompressions, vestibular nerve sections and posterior cranial fossa surgeries. Each cranial nerve electrode kit includes: one 2.0 mm or 3.0 mm cranial nerve electrode with a platinum contact, one 25 cm long applicator wand & one 6 foot (1.8 m) lead wire terminating in a 1.5 mm safety socket. Each middle fossa electrode kit includes: one electrode with a 2.35 mm diameter platinum contact (the black mark indicates the non-recording side) and one 6 foot (1.8 m) lead wire terminating in a 1.5 mm safety socket. All lead wires are 6 feet (1.8 m) long. All lead wires interface with standard EEG/EP amplifiers using 1.5 mm safety sockets. Contact your Ad-Tech representative for alternative termination options. Quantity discounts are available on all cranial nerve electrodes. Consult the current price sheet for details.
    Info Ad-Tech Medical
    Customer Service: (800) 776-1555
    Web site: http://www.adtechmedical.com

    Related medicine products :

    1. Adson Cranial Rongeur
    2. Bacon Cranial Rongeur
    3. Instatrak - Cranial
    4. Neuroclip Cranial Flap Fixation System
    5. TEW Cranial/Spinal Retractor (A 1090)
    6. De Vilbiss Cranial Rongeur
    7. Stookey Cranial Rongeur
    8. Marchac Cranial Rongeur
    9. Cranial Drill
    10. Hudson Cranial Drill
    11. Tew Cranial/Spinal Retractor
    Full Handle Laseredge Implant Blade Knife, 5.2 mm straight. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
    Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
    Full Handle Laseredge Crescent Blade Knife, angled double bevel. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
    Full Handle Laseredge Crescent Blade Knife, angled bevel up. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
    Medicine Products:
    (Date:6/17/2013)... NY (PRWEB) June 17, 2013 The Woodstock ... Blake to attend the Festival this summer, which will be ... through Sunday, August 25th. , Blake professes the benefits ... a day to fuel his world class sprinting abilities. ... volume of fruit is drawing attention. "Yohan Blake believes in ...
    (Date:6/17/2013)... City Beach, FL (PRWEB) June 17, 2013 ... higher purpose--fighting hunger. Oceana Naturals LLC, the US distributor ... region of The Bay Area Food Bank ... families, and struggling seniors by seeing that they receive ... Natural Sunscreen and All Natural Moisturizer. Contributions will ...
    (Date:6/17/2013)... (June 17, 2013) A team from the New ... Naomi Berrie Diabetes Center of Columbia University has generated ... the features of maturity-onset diabetes of the young (MODY). ... patients to produce induced pluripotent stem (iPS) cells, from ... mouse, the stem cell-derived beta cells secreted insulin in ...
    (Date:6/17/2013)... Keller, TX (PRWEB) June 17, 2013 Tarrant ... special. , The term ‘mommy makeover’ has recently undergone ... from surgeon to surgeon. At Tarrant Plastic Surgery, they regard ... procedures designed to remove and reverse many of the effects ... the breast may typically include: drooping of the breast with ...
    (Date:6/17/2013)... new drug called pyrvinium pamoate inhibits aggressive forms of ... to a study conducted in an animal model. The ... 95th Annual Meeting in San Francisco. , "Our novel ... action," said study lead author Jeremy Jones, PhD, assistant ... Research Institute, in Duarte, CA. "Thus, it has the ...
    Breaking Medicine News(10 mins):Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2Health News:New medication treats drug-resistant prostate cancer in the laboratory 2
    ... Delhi is planning to interlink its major 29 hospitals ... and treatment provided. This computerization and interlinking of data ... by which doctors can know the case history and ... modules of software to deal with different hospital departments. ...
    ... number of psychiatric disorders, including mood disorders, schizophrenia// ... shown to increase the risk for emergence of ... disorder), and that presence of certain anxiety disorders ... development of nicotine dependence. ,A recent study ...
    ... or growing fast: systematic review of size and growth ... who grow rapidly during the first two years of life, ... a study reveals. ,There is an urgent need to ... is not clear how early in life prevention could begin. ...
    ... is no link whatsoever between breast cancer and cholesterol levels ... control the same. ,The details of the study ... Internal Medicine, one of the JAMA/Archives journals. The article says ... to suggest that the statins may work in conjunction with ...
    ... compulsory licensing (CL) provision in the Patents Act that ... Swiss drug maker Roche’s patented drug Tamiflu, useful in ... flu virus. , ,Section 92 empowers the government ... the industry. Furthermore, the issue of such license is ...
    ... a large, heterogeneous group of rare pulmonary disorders ... abnormal gas exchange with considerable mortality and morbidity. ... diagnosis includes more than 100 conditions in both ... and Colorado conducted a descriptive, observational study was ...
    Cached Medicine News:Health News:Delhi Government To Interlink All Major Hospitals Through e-Governance 2Health News:Smokers Are Prone To Number Of Psychiatric Disorders 2Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
    (Date:6/17/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... ENDO 2013, the Endocrine Society,s 95 th ... both melatonin and cortisol rhythms. This effect further ... clock and address the circadian desynchrony which is ... and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study ...
    (Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
    (Date:6/17/2013)... June 17, 2013 The following is a Statement ... at Drugfree.org :   Last Friday, ... was halting the sale of prescription drug paraphernalia products. The ... that from time to time there may be individual items ... As a result of this misinterpretation we are electing to ...
    Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2